PD-1 and PD-L1 Expression in Osteosarcoma: Which Specimen to Evaluate?

Chen, Sonja; Guenther, Lillian M; Aronhalt, Amanda; Cardillo, Lacey; Janeway, Katherine A; Church, Alanna J

Chen, Sonja; Guenther, Lillian M; Aronhalt, Amanda; Cardillo, Lacey; Janeway, Katherine A; Church, Alanna J.

Afiliação

Chen S; Department of Pathology, Boston Children's Hospital.
Guenther LM; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Aronhalt A; Department of Pathology, Boston Children's Hospital.
Cardillo L; Department of Pathology, Boston Children's Hospital.
Janeway KA; Pediatric Oncology, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.
Church AJ; Department of Pathology, Boston Children's Hospital.

J Pediatr Hematol Oncol ; 42(8): 482-487, 2020 11.

Article em En | MEDLINE | ID: mdl-31842180

Assuntos

Antígeno B7-H1/análise; Neoplasias Ósseas/química; Osteossarcoma/química; Receptor de Morte Celular Programada 1/análise; Adolescente; Biópsia; Neoplasias Ósseas/patologia; Criança; Feminino; Humanos; Masculino; Metastasectomia; Necrose; Osteossarcoma/patologia; Osteossarcoma/secundário; Linfócitos T/patologia; Adulto Jovem

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ósseas / Osteossarcoma / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 Limite: Adolescent / Adult / Child / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google